Cargando…

Network Pharmacology and Molecular Docking Analysis on Pharmacological Mechanisms of Astragalus membranaceus in the Treatment of Gastric Ulcer

BACKGROUND: Astragalus membranaceus (AM, family: Leguminosae) exerts significant therapeutic effect on gastric ulcer (GU); however, there are scarce studies on its molecular mechanism against GU. This study aims to explore the key ingredients, key targets, and potential mechanisms of AM in the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Piao, Zhou, Rui, Min, Yao, An, Li-Ping, Wang, Fei, Du, Quan-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820867/
https://www.ncbi.nlm.nih.gov/pubmed/35140802
http://dx.doi.org/10.1155/2022/9007396
_version_ 1784646297506021376
author Zhou, Piao
Zhou, Rui
Min, Yao
An, Li-Ping
Wang, Fei
Du, Quan-Yu
author_facet Zhou, Piao
Zhou, Rui
Min, Yao
An, Li-Ping
Wang, Fei
Du, Quan-Yu
author_sort Zhou, Piao
collection PubMed
description BACKGROUND: Astragalus membranaceus (AM, family: Leguminosae) exerts significant therapeutic effect on gastric ulcer (GU); however, there are scarce studies on its molecular mechanism against GU. This study aims to explore the key ingredients, key targets, and potential mechanisms of AM in the treatment of GU by utilizing network pharmacology and molecular docking. METHODS: Several public databases were used to predict the targets of AM and GU, respectively, and the drug and disease targets were intersected to obtain the common targets. Next, the key ingredients and key targets were identified by constructing ingredient-target network and protein-protein-interaction (PPI) network. Gene Ontology biological processes (GOBP) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were carried out on the common targets in order to ascertain the biological processes and signaling pathways involved. Finally, molecular docking was conducted to verify the binding affinity between the key ingredients and key targets. RESULTS: A total of 552 predicted targets were obtained from 23 screened active ingredients, of which 203 targets were the common targets with GU. Quercetin, kaempferol, and isorhamnetin were identified as the key ingredients by constructing ingredient-target network, and TP53, AKT1, VEGFA, IL6, TNF, CASP3, and EGFR were selected as the key targets by constructing PPI network. GOBP and KEGG pathway enrichment analysis suggested that the therapeutic effect of AM on GU involved multiple biological processes and signaling pathways related to inflammation, oxidative stress, apoptosis, cell proliferation, and angiogenesis. Molecular docking validation demonstrated that all key ingredients had good binding affinity with the key targets. CONCLUSION: This study revealed the key ingredients, key targets, and potential mechanisms of AM against GU, and these data may provide some crucial references for subsequent research and development of drugs for treating GU.
format Online
Article
Text
id pubmed-8820867
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-88208672022-02-08 Network Pharmacology and Molecular Docking Analysis on Pharmacological Mechanisms of Astragalus membranaceus in the Treatment of Gastric Ulcer Zhou, Piao Zhou, Rui Min, Yao An, Li-Ping Wang, Fei Du, Quan-Yu Evid Based Complement Alternat Med Research Article BACKGROUND: Astragalus membranaceus (AM, family: Leguminosae) exerts significant therapeutic effect on gastric ulcer (GU); however, there are scarce studies on its molecular mechanism against GU. This study aims to explore the key ingredients, key targets, and potential mechanisms of AM in the treatment of GU by utilizing network pharmacology and molecular docking. METHODS: Several public databases were used to predict the targets of AM and GU, respectively, and the drug and disease targets were intersected to obtain the common targets. Next, the key ingredients and key targets were identified by constructing ingredient-target network and protein-protein-interaction (PPI) network. Gene Ontology biological processes (GOBP) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were carried out on the common targets in order to ascertain the biological processes and signaling pathways involved. Finally, molecular docking was conducted to verify the binding affinity between the key ingredients and key targets. RESULTS: A total of 552 predicted targets were obtained from 23 screened active ingredients, of which 203 targets were the common targets with GU. Quercetin, kaempferol, and isorhamnetin were identified as the key ingredients by constructing ingredient-target network, and TP53, AKT1, VEGFA, IL6, TNF, CASP3, and EGFR were selected as the key targets by constructing PPI network. GOBP and KEGG pathway enrichment analysis suggested that the therapeutic effect of AM on GU involved multiple biological processes and signaling pathways related to inflammation, oxidative stress, apoptosis, cell proliferation, and angiogenesis. Molecular docking validation demonstrated that all key ingredients had good binding affinity with the key targets. CONCLUSION: This study revealed the key ingredients, key targets, and potential mechanisms of AM against GU, and these data may provide some crucial references for subsequent research and development of drugs for treating GU. Hindawi 2022-01-31 /pmc/articles/PMC8820867/ /pubmed/35140802 http://dx.doi.org/10.1155/2022/9007396 Text en Copyright © 2022 Piao Zhou et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zhou, Piao
Zhou, Rui
Min, Yao
An, Li-Ping
Wang, Fei
Du, Quan-Yu
Network Pharmacology and Molecular Docking Analysis on Pharmacological Mechanisms of Astragalus membranaceus in the Treatment of Gastric Ulcer
title Network Pharmacology and Molecular Docking Analysis on Pharmacological Mechanisms of Astragalus membranaceus in the Treatment of Gastric Ulcer
title_full Network Pharmacology and Molecular Docking Analysis on Pharmacological Mechanisms of Astragalus membranaceus in the Treatment of Gastric Ulcer
title_fullStr Network Pharmacology and Molecular Docking Analysis on Pharmacological Mechanisms of Astragalus membranaceus in the Treatment of Gastric Ulcer
title_full_unstemmed Network Pharmacology and Molecular Docking Analysis on Pharmacological Mechanisms of Astragalus membranaceus in the Treatment of Gastric Ulcer
title_short Network Pharmacology and Molecular Docking Analysis on Pharmacological Mechanisms of Astragalus membranaceus in the Treatment of Gastric Ulcer
title_sort network pharmacology and molecular docking analysis on pharmacological mechanisms of astragalus membranaceus in the treatment of gastric ulcer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820867/
https://www.ncbi.nlm.nih.gov/pubmed/35140802
http://dx.doi.org/10.1155/2022/9007396
work_keys_str_mv AT zhoupiao networkpharmacologyandmoleculardockinganalysisonpharmacologicalmechanismsofastragalusmembranaceusinthetreatmentofgastriculcer
AT zhourui networkpharmacologyandmoleculardockinganalysisonpharmacologicalmechanismsofastragalusmembranaceusinthetreatmentofgastriculcer
AT minyao networkpharmacologyandmoleculardockinganalysisonpharmacologicalmechanismsofastragalusmembranaceusinthetreatmentofgastriculcer
AT anliping networkpharmacologyandmoleculardockinganalysisonpharmacologicalmechanismsofastragalusmembranaceusinthetreatmentofgastriculcer
AT wangfei networkpharmacologyandmoleculardockinganalysisonpharmacologicalmechanismsofastragalusmembranaceusinthetreatmentofgastriculcer
AT duquanyu networkpharmacologyandmoleculardockinganalysisonpharmacologicalmechanismsofastragalusmembranaceusinthetreatmentofgastriculcer